Sie weiterhin diese Meldung erhalten, informieren Sie uns darber bitte per E-Mail CHICAGO, Nov. 2, 2022 /PRNewswire/ -- GTCR, a leading private equity firm, announced today that it has made a strategic, majority investment in Biocoat Holdings, LLC ("Biocoat" or the. Wenn Aidez-nous protger Glassdoor en confirmant que vous tes une personne relle. from 8 AM - 9 PM ET.
Buyout Firm GTCR Weighs Sale of Drug Company TerSera Blackstone is one of the worlds leading investment firms. The partnership will provide GTCRs portfolio companies with access to Blackstones group purchasing program, which leverages the buying power of the $150 billion revenue base across Blackstones entire investment platform. verdade. Founded in 1991 and headquartered in Horsham, Pennsylvania, Biocoat is a leading medical device contract manufacturing organization ("CMO"), specializing in custom, biocompatible hydrophilic coatings for interventional medical devices. las molestias.
PDF Platforms Add-ons 14b+ Kirkland & Ellis served as legal counsel to GTCR and Fried Frank served as legal counsel to Blackstone. Over the past 31 years, Biocoat has developed a diverse base of both blue-chip and emerging medical device customers, a highly experienced team of engineers and scientists, and state-of-the-art manufacturing and R&D facilities. GTCR Golder Rauner is a privately held investment firm that focuses on such industries as financial services, health care, technology, and . Evercore served as financial advisor to GTCR. Founded in 1980, GTCR is a leading private equity firm focused on investing in growth companies in the Business & Consumer Services, Financial Services & Technology, Healthcare, and Technology, and Media & Telecommunications industries. Get the full list, Youre viewing 5 of 216 team members. Since its inception, GTCR has invested more than $20 billion in over 250 companies. You will be charged Paula Chirhart The Chicago-based firm pioneered The Leaders Strategy - finding and partnering with management leaders in core domains to identify, acquire and build market-leading companies through transformational acquisitions and organic growth. For more information, please visit www.gtcr.com. Win whats next. Following its separation from Thoma Cressey (discussed above), GTCR has raised seven private equity funds totaling $20 billion in limited partner commitments: Language links are at the top of the page across from the title. Disculpa GTCR has a longstanding relationship with Mr. Hance, having originally partnered with him to form Regatta Medical in 2017 as a Leaders Strategy partnership to pursue opportunities in the medical device industry and acquired Resonetics, a leading medical device contract manufacturer, in February 2018. Based in Nashville, Tennessee, PathGroup is one of the largest independent laboratories in the United States. [2] As of 2021, the firm has more than 80 employees, including over 40 investment professionals. GTCR is a leading growth-oriented private equity firm with a management-driven approach and business-building investment orientation. Further information is available at www.blackstone.com. Jim TenBroek is a co-founder and Managing Partner of GCP. GTCR LLC | 12,402 followers on LinkedIn. As part of The Leaders Strategy, GTCR will again partner with industry veteran Chip Hance, the current Chairman of GTCR portfolio company Regatta Medical Holdings, LLC (d/b/a "Resonetics"), who will join Biocoat as Executive Chairman.
GTCR Investor Profile: Portfolio & Exits | PitchBook This platform enables the Company to work with its customers across a wide range of interventional products and medical device segments, including neurovascular, ophthalmology, cardiovascular and other interventional specialties. Follow GTCR on LinkedIn. Blackstones GP Stakes business specializes in value-added, long-term partnerships with leading private-market alternative asset management firms. "Biocoat has an excellent track record of developing high-quality biocompatible medical coatings formulations using innovative technologies, and we look forward to investing additional capital to support both organic initiatives and strategic follow-on acquisitions in the medical coatings and broader biomaterials sector," said GTCR Managing Director Luke Marker.
GTCR Chicago Private Equity Firm GTCR 's most notable exits include Vivid Seats , Maravai Life Sciences , and Gogo. Founded in 1991, Biocoat is a leading provider of medical coatings products and services for medical devices in the fast-growing interventional sector. Private Equity Round - Senske Lawn & Tree Care, Private Equity Round - Visionary Broadband, Private Equity Round - PPC Flexible Packaging, Private Equity Round - Global Claims Services, Private Equity Round - Jet Support Services, Private Equity Round - Antylia Scientific, Diversity Spotlight (US Headquarters Only), Private Equity Round - Vector Laboratories, Wells Fargo Asset Management acquired by GTCR, Total number of diversity investments made by an investor. Since its inception, GTCR has invested more than $20 billion in over 250 companies. To view recent press releases,click here. GTCR has a longstanding relationship with Mr. Hance, having originally partnered with him to form Regatta Medical in 2017 as a Leaders Strategy partnership to pursue opportunities in the medical device industry and acquired Resonetics, a leading medical device contract manufacturer, in February 2018. This platform enables the Company to work with its customers across a wide range of interventional products and medical device segments, including neurovascular, ophthalmology, cardiovascular and other interventional specialties. Since its inception, GTCR has invested more than $24 billion in over 270 companies, and the firm currently manages over $27 billion in equity capital. You may change your billing preferences at any time in the Customer Center or call kelliek@theharbingergroup.com, Internet Explorer presents a security risk. GTCR has deep expertise in the healthcare and lab testing industries and will leverage its prior investment history and resources to help support the continued growth of the Company alongside the PathGroup team.
GTCR Appoints Don McDonough to Lead Business Development for its To receive email alerts from Blackstone, sign up below. The terms of the transaction were not disclosed.
Existing Biocoat management and 1315 Capital, the selling equity sponsor, will retain minority stakes in the Company. 60654 GTCR Fund XII, the firm's largest fund to date, with $5.25 billion of limited partner equity capital commitments. GTCR, a leading private equity firm, announced today that it has made a majority investment in PathGroup Holdings LLC ("PathGroup" or the "Company") in partnership with founder and CEO Ben Davis .
Private Equity Health Care Acquisitions - March 2021 I have been personally gratified to develop rapport with the GTCR team, and we look forward to our long-term partnership., Ward Young, GP Stakes Managing Director added, Our top priority is to partner with the most successful general partners in private equity. This website uses cookies, including third-party cookies, in order to obtain information about your visit to the website and make this website better. Aiutaci a proteggere Glassdoor dimostrando che sei una persona reale. an. Follow us on LinkedIn.
2023 PitchBook. los inconvenientes que esto te pueda causar. About GTCRFounded in 1980, GTCR is a leading private equity firm focused on investing in growth companies in the Business & Consumer Services, Financial Services & Technology, Healthcare and Technology, Media & Telecommunications industries. Under the original application, each investment was expected to adhere to risk standards on its own merits, limiting the ability of investment managers to make any investments deemed potentially risky. Chicago-based private equity firm GTCR is considering a sale of TerSera Therapeutics LLC that could value the specialty pharmaceutical company at more than $1 billion, according to people familiar . In particular, we believe that this investment partnership will further enhance our ability to serve the interests of our limited partners, our management partners and our investment team and staff. We are pleased to support GTCRs ongoing success.. Already a subscriber? The firm became Golder Thoma & Cressey in 1984, and with the promotion of Bruce Rauner to partner the firm would come to be known as Golder, Thoma, Cressey, Rauner, Inc. (GTCR), although it would still often be referred to as Golder Thoma.[7]. Illinois Venture Capital Association (IVCA2), Youre viewing 5 of 800 investments and acquisitions. GTCR understands the dynamics of business transformation through acquisitions, consolidations and internal growth. Wells Fargo Company (NYSE: WFC) today announced that it has entered into a definitive agreement to sell Wells Fargo Asset Management (WFAM) to GTCR LLC and Reverence Capital Partners, L.P. We seek to create positive economic impact and long-term value for our investors, the companies we invest in, and the communities in which we work. Under Mr. Hance's leadership, Resonetics has completed 10 add-on acquisitions, generated significant organic growth, and executed a successful partial sale for a minority stake of Resonetics at a $2.25 billion enterprise value in November 2021. Help ons Glassdoor te beschermen door te verifiren of u een persoon bent. naar A Leader in Private Equity for Over 40 Years | Founded in 1980, GTCR is a leading private equity firm that pioneered The Leaders Strategy - finding . Sean Cunningham, GTCR Managing Director and Co-Head of Healthcare, added: "This investment demonstrates GTCR's continued commitment to The Leaders Strategy, as we find ways to partner with experienced management teams. All rights reserved. Join Mergr to view GTCRs full profile and discover more Since its inception, GTCR has invested more than $24 billion in over 270 companies, and the firm currently manages over $27 billion in equity capital. For more information, please visit www.gtcr.com. Ajude-nos a manter o Glassdoor seguro confirmando que voc uma pessoa de om ons te informeren over dit probleem. Customer Service.
Working at GTCR | Glassdoor Further information is available at www.blackstone.com. Environmental, Social and Governance (ESG), HVAC (Heating, Ventilation and Air-Conditioning), Machine Tools, Metalworking and Metallurgy, Aboriginal, First Nations & Native American, GTCR Becomes Signatory to United Nations-Supported Principles for Responsible Investment. Prior to partnering with GTCR, Mr. Hance served as Chief Executive Officer of Creganna Medical, a leading supplier of contract manufacturing services for medical devices, where he significantly grew the business via acquisitions and organic growth before completing a successful sale of the company in 2016 to TE Connectivity. About GTCR Founded in 1980, GTCR is a leading private equity firm focused on investing in growth companies in the Healthcare, Financial Services & Technology, Technology, Media .
Jim Tenbroek Growth Catalyst Partners Leaders Strategy Investment to Support Growth and Expansion of Biocompatible Medical Device Coatings Provider. Which industries has this organization had the most exits in? Sign In. To explore GTCRs full profile, request access. Park Place Technologies is an IT company that provided organizations around the globe with post-warranty maintenance and support solutions. Going forward, the existing Biocoat management team, led by CEO Jim Moran, will continue in their existing roles executing on Biocoat's growth initiatives in partnership with GTCR. In particular, we believe that this investment partnership will further enhance our ability to serve the interests of our limited partners, our management partners and our investment team and staff. The Chicago-based firm is targeting $9.5 billion for GTCR Fund XIV, which will take control positions in companies across the healthcare, business services, financial services and technology industries, according to documents prepared for Maine Public Employees Retirement System. If you continue to see this For information on our privacy practices see our Privacy Policy. Since its inception, GTCR has invested more than$20 billionin over 250 companies. How many investments has this organization made over time? The fund supports GTCR's Leaders Strategy investment approach for smaller opportunities than those pursued by its most recent flagship fund, GTCR Fund XIII, which closed in 2020 with $7.5 . In 2020, GTCR closed on its thirteenth equity fund, GTCR Fund . We are especially impressed with GTCRs strategy of investing in transformative growth behind talented executives. questo messaggio, invia un'email all'indirizzo Piper Sandler served as exclusive financial advisor to Biocoat. per informarci del problema. Financial Advisors, visit our dedicated website to learn how you can partner with Blackstone. message, please email Sean Cunningham, GTCR Managing Director and Co-Head of Healthcare, added: "This investment demonstrates GTCR's continued commitment to The Leaders Strategy, as we find ways to partner with experienced management teams. Both firms continue to invest primarily through consolidations of specific industries, referred to as roll-ups: GTCR invests through a series of private limited partnerships and its investors include a variety of pension funds (e.g., Washington State Investment Board,[12] Pennsylvania State Employee's Retirement System[13]) endowments and other institutional investors. "Jim Moran and the Biocoat team have built an exciting platform company," said Chip Hance. Maravai is a life sciences company providing critical products to enable the development of drug therapies, diagnostics, novel vaccines. We look forward to supporting Chip, Jim, and the Biocoat team as the Company continues its aggressive pursuit of follow-on acquisitions in the next chapter of its growth.". Pritzker Private Capital and Vesey Street Capital Partners will also be retaining a minority ownership stake in the Company alongside GTCR and the PathGroup management team.